Life Sciences Vertical Subpack (S3.3)

Key life sciences KPIs for value selling include 22 domain-specific metrics covering enrollment, regulatory CMC, pharmacovigilance, manufacturing, and RWE. These KPIs connect R&D-to-commercialization activities with financially meaningful outcomes for pharma, biotech, and CRO stakeholders.

To quantify lifecycle economics for a pharma asset, apply the subpack's 12 value formulas and 22 KPIs across discovery, regulatory approval, and market access stages. This enables ROI-focused value propositions using governance-aligned benchmarks and evidence sources.

The subpack supports cell and gene therapy use cases alongside pharma, biotech, medical devices, IVDs, CROs, and CDMOs. It provides domain-specific pains, KPIs, signals, personas, and value drivers tailored to CGT across the discovery-to-commercialization lifecycle.

You can evaluate clinical trial enrollment risk by loading the Life Sciences Vertical Subpack and starting with LS-P001. This entry point assesses enrollment risk and related KPIs for a flagship asset, enabling precise, ROI-focused conversations with stakeholders.

The subpack includes 6 vertical personas and 14 buying triggers designed to drive targeted value conversations with CRO and CDMO stakeholders. These components support lifecycle management and portfolio decisions from discovery to commercialization.

Governance-aligned benchmarks for regulatory CMC and pharmacovigilance are provided within the subpack's framework. It includes 18 vertical pains, 22 KPIs, and evidence sources aligned to the master taxonomy for precise ROI-focused value propositions.